Status: current, Defined. Date: 31-Mar 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4785501000168118 | Tobeta-XL (metoprolol succinate 23.75 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4785511000168115 | Tobeta-XL 23.75 mg modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobeta-XL 23.75 mg modified release tablet | Is a | Tobeta-XL | true | Inferred relationship | Some | ||
| Tobeta-XL 23.75 mg modified release tablet | Is a | metoprolol succinate 23.75 mg modified release tablet | true | Inferred relationship | Some | ||
| Tobeta-XL 23.75 mg modified release tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tobeta-XL 23.75 mg modified release tablet | has manufactured dose form | modified release tablet | true | Inferred relationship | Some | ||
| Tobeta-XL 23.75 mg modified release tablet | has unit of use | tablet | true | Inferred relationship | Some | 141862782 | |
| Tobeta-XL 23.75 mg modified release tablet | has intended active ingredient | metoprolol | true | Inferred relationship | Some | 759751450 | |
| Tobeta-XL 23.75 mg modified release tablet | has Australian BoSS | metoprolol succinate | true | Inferred relationship | Some | 759751450 |
Reference Sets
Trade product unit of use reference set
FHIR